Fighting Cancer: Epigenetic Targets for Oncology

February 23, 2016

Epigenetics refers to heritable changes characteristics that can be influences by the environment, but which do not result from changes in the genetic code. Epigenetics is an area of intense current interest in medicinal chemistry, biology, and medicine. Professor Stuart Conway will introduce current understanding of the molecular basis of epigenetic processes, and explain how these findings are being exploited in medicinal chemistry to develop medicines with innovative new mechanisms of action.

Register Now!

What You Will Learn

• A general discussion the molecular components of epigenetics, the epigenetic code hypothesis, and the role of DNA and histone modifications.
• An overview of epigenetic drug classes, including HDACs, methyltransferase inhibitors, demthylase inhibitors, and bromodomain ligands.
• Update on the clinical progress of epigenetic drugs, with a particular focus on newer drug targets, especially “readers”.

• Date: Thursday, February 23, 2017 @ 1 - 2pm CT
• Fee: Free to Attend
• Download Slides: Available Day of Broadcast